Get the Stockscreener App
1.63
2.20%
0.04
Biomea Fusion Inc stock is traded at $1.63, with a volume of 771.52K.
It is up +2.20% in the last 24 hours and down -3.85% over the past month.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.
See More
Previous Close:
$1.59
Open:
$1.64
24h Volume:
771.52K
Relative Volume:
0.33
Market Cap:
$61.05M
Revenue:
-
Net Income/Loss:
$-144.01M
P/E Ratio:
-0.4065
EPS:
-4.01
Net Cash Flow:
$-113.02M
1W Performance:
-2.11%
1M Performance:
-3.85%
6M Performance:
-56.61%
1Y Performance:
-71.84%
1-Day Range:
$1.58
$1.70
1-Week Range:
$1.50
$1.70
52-Week Range:
$1.2905
$13.07
Biomea Fusion Inc Stock (BMEA) Company Profile
Name
Biomea Fusion Inc
Sector
Industry
Phone
(650) 980-9099
Address
1599 INDUSTRIAL ROAD, SAN CARLOS
Compare BMEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.625 | 90.10M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.43 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.36 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.06 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
670.26 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
295.09 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Resumed | Piper Sandler | Overweight |
| Oct-09-24 | Initiated | Edward Jones | Buy |
| Sep-27-24 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Sep-27-24 | Upgrade | Truist | Hold → Buy |
| Aug-29-24 | Initiated | CapitalOne | Overweight |
| Jun-11-24 | Downgrade | Truist | Buy → Hold |
| Jun-07-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-06-24 | Initiated | Truist | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Jun-26-23 | Downgrade | Jefferies | Buy → Hold |
| May-12-23 | Initiated | Barclays | Overweight |
| Mar-29-23 | Reiterated | Oppenheimer | Outperform |
| Mar-28-23 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-23 | Initiated | Citigroup | Buy |
| Jun-02-22 | Resumed | H.C. Wainwright | Buy |
| Jan-12-22 | Initiated | H.C. Wainwright | Buy |
| Dec-17-21 | Initiated | Oppenheimer | Outperform |
| May-11-21 | Initiated | JP Morgan | Overweight |
| May-11-21 | Initiated | Jefferies | Buy |
| May-11-21 | Initiated | Piper Sandler | Overweight |
View All
Biomea Fusion Inc Stock (BMEA) Latest News
Biomea Fusion Reports Q2 2025 Financial Results - TipRanks
Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire
Biomea Fusion (BMEA) Q2 Loss Drops 44% - The Motley Fool
Biomea Fusion Trims Losses As Investors Hold Out Hope - Finimize
Biomea Fusion Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biomea Fusion Q2 net loss narrows to $20.7 mln - MarketScreener
Biomea Fusion's $300M Shelf Filing: A Strategic Play in a High-Stakes Biotech Market - AInvest
Biomea Fusion files $300M mixed-securities shelf - AInvest
RENEW 8-K: Ninth SPAC Extension Adds $250k to Trust, Deadline Sep 5 2025 | BMEA SEC FilingForm 8-K - Stock Titan
How volatile is Biomea Fusion Inc. stock compared to the marketDiscover undervalued opportunities early - Jammu Links News
What are analysts’ price targets for Biomea Fusion Inc. in the next 12 monthsFree Stock Chart Pattern Guide - Jammu Links News
Biomea Fusion Inc. Stock Analysis and ForecastUnstoppable investment returns - Jammu Links News
Is Biomea Fusion Inc. a growth stock or a value stockUnlock your portfolio’s hidden potential - Jammu Links News
What is the risk reward ratio of investing in Biomea Fusion Inc. stockBuild wealth with high-performing stocks - Jammu Links News
What markets is Biomea Fusion Inc. expanding into Is MAMO stock a good long term investment option - Jammu Links News
Should I hold or sell Biomea Fusion Inc. stock in 2025Rapidly growing investment returns - Jammu Links News
What makes Biomea Fusion Inc. stock price move sharplyConsistently exceptional gains - Jammu Links News
What is the dividend policy of Biomea Fusion Inc. stockAchieve consistent profits with proven strategies - Jammu Links News
Is it the right time to buy Biomea Fusion Inc. stockBuild a winning investment strategy today - Jammu Links News
What analysts say about Biomea Fusion Inc. stockAchieve rapid portfolio growth with smart picks - Jammu Links News
What are the latest earnings results for Biomea Fusion Inc.Invest in stocks with long-term growth potential - Jammu Links News
What catalysts could drive Biomea Fusion Inc. stock higher in 2025Discover the next big stock winners - Jammu Links News
Does Biomea Fusion Inc. stock perform well during market downturnsDynamic profit expansion - jammulinksnews.com
Will Biomea Fusion Inc. benefit from macro trendsTriple Return Setup With Risk Control Explained - metal.it
Key resistance and support levels for Biomea Fusion Inc.Fast Exit and Entry Strategy Guide Offered - metal.it
How Biomea Fusion Inc. stock performs during market volatilityStock Market Watch With Alerts Shows Unusual Activity - metal.it
Quant Strategy Flags Biomea Fusion Inc. for EntryQuick Gain Stock Watch With Indicators Reviewed - metal.it
Biomea Fusion Inc expected to post a loss of 53 cents a shareEarnings Preview - TradingView
Quant Tools Rank Biomea Fusion Inc. as High Risk High RewardBreakout Entry Signal Confirmation Tool Used - metal.it
Recovery Setup Building in Biomea Fusion Inc. Experts SayPattern Detection for Entry Confirmation Enabled - metal.it
Why Biomea Fusion Inc. stock attracts strong analyst attentionPattern Breakout Entry Stock Forecast in Focus - metal.it
Biomea Fusion Inc. Hits Oversold Level on RSI IndicatorWeekly Stock Watch With Growth Focus Expanded - metal.it
Biomea Fusion BMEA 2025Q2 Earnings Preview Downside Risk Amid EPS Estimate Revisions - AInvest
Published on: 2025-07-28 06:30:27 - Jammu Links News
Is Biomea Fusion Inc. a Top Dividend Stock to Watch in 2025Free Smart Investment Opportunities - metal.it
Is Biomea Fusion Inc. stock overvalued or undervaluedExponential return rates - jammulinksnews.com
Biomea Fusion Announces Leadership Changes in Board - The Globe and Mail
Biomea Fusion (BMEA) Upgraded to Buy: Here's What You Should Know - MSN
Biomea Fusion Inc Stock (BMEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):